V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002483 | 230006905 | null | null | Adjuvant (A) | 2017-04-14 | 2017-06-02 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101660639 |
| 230002484 | 230006906 | null | null | Neo-adjuvant (N) | 2018-08-07 | 2018-08-16 | Niraparib | 02 | N | NIRAPARIB | 101190704 |
| 230002485 | 230006907 | 1.62 | 79.2 | null | 2020-12-26 | 2021-01-24 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 100995054 |
| 230002486 | 230006908 | 1.56 | 68.4 | null | null | 2020-01-29 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100313597 |
| 230002487 | 230006909 | 1.57 | 55 | Adjuvant (A) | 2019-05-12 | 2019-05-15 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101429779 |
| 230002490 | 230006911 | 1.51 | 81.4 | Adjuvant (A) | 2018-08-11 | 2018-08-16 | null | 02 | N | IPILIMUMAB + NIVOLUMAB | 100598119 |
| 230002496 | 230006916 | 1.62 | 59 | null | 2018-10-16 | 2019-05-07 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100025980 |
| 230000127 | 230006917 | null | null | null | 2020-01-09 | 2020-01-10 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101739748 |
| 230000394 | 230006921 | 1.48 | 86.1 | null | 2021-07-23 | 2021-07-31 | null | null | null | PACLITAXEL | 100919016 |
| 230000396 | 230006922 | 1.49 | 57 | null | null | 2019-11-21 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100000787 |
| 230000408 | 230006923 | 1.6 | 94.55 | Neo-adjuvant (N) | 2020-01-09 | 2020-01-09 | null | null | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100874156 |
| 230000533 | 230006926 | 1.67 | 65.9 | Curative (C) | null | 2021-08-16 | Rucaparib | 02 | N | RUCAPARIB | 100809809 |
| 230000660 | 230006927 | 1.7 | 71.55 | Palliative (P) | null | 2018-12-27 | Olaparib | 02 | N | OLAPARIB | 101858698 |
| 230000677 | 230006928 | 1.59 | 69.3 | Adjuvant (A) | 2020-12-12 | 2021-03-24 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101324249 |
| 230000680 | 230006929 | 1.65 | 69.8 | null | null | 2020-03-13 | null | null | null | OLAPARIB | 100052373 |
| 230000703 | 230006931 | 1.7 | 83.85 | null | 2019-12-30 | 2019-12-30 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101564626 |
| 230000792 | 230006933 | null | null | null | 2020-07-11 | 2020-08-09 | null | null | null | NIRAPARIB | 101743297 |
| 230000798 | 230006934 | 1.67 | 118.5 | null | 2021-07-06 | 2021-08-10 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100294403 |
| 230000869 | 230006935 | null | null | Palliative (P) | null | 2020-10-22 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101278961 |
| 230000914 | 230006936 | null | null | null | 2020-08-31 | 2020-09-07 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100620935 |
| 230000965 | 230006938 | 1.67 | 91.8 | Neo-adjuvant (N) | 2021-01-28 | 2021-02-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101177171 |
| 230001004 | 230006939 | 1.62 | 65 | null | 2019-10-14 | 2019-10-27 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101112025 |
| 230001007 | 230006940 | 1.69 | 54 | null | 2021-05-26 | 2021-07-22 | null | 01 | null | CETUXIMAB | 100670947 |
| 230001176 | 230006944 | null | null | Palliative (P) | 2019-06-28 | 2019-07-05 | Rucaparib | 02 | N | RUCAPARIB | 101863872 |
| 230001287 | 230006946 | 1.53 | 55.9 | null | 2019-07-09 | 2021-11-18 | Bevacizumab | 02 | null | BEVACIZUMAB | 101594861 |
| 230001356 | 230006948 | null | null | null | 2019-12-24 | 2019-12-24 | Olaparib | 02 | null | OLAPARIB | 100731937 |
| 230001395 | 230006949 | 1.74 | 103 | null | 2019-08-24 | 2020-02-10 | null | null | null | PEMBROLIZUMAB | 100397809 |
| 230001437 | 230006950 | 1.66 | 107.3 | Palliative (P) | null | 2020-04-02 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101374920 |
| 230001623 | 230006953 | 1.6 | 105 | null | 2017-10-02 | 2017-10-28 | NAB PACLITAXEL | 02 | null | CISPLATIN | 101131334 |
| 230001657 | 230006954 | null | null | null | 2021-01-14 | 2021-01-31 | null | 02 | null | TRASTUZUMAB EMTANSINE | 101223342 |
| 230001703 | 230006955 | null | null | null | 2020-12-29 | 2021-06-13 | null | null | null | CARBOPLATIN + GEMCITABINE | 100273130 |
| 230001705 | 230006956 | null | null | null | 2019-07-22 | 2019-07-29 | null | null | null | OLAPARIB | 100443175 |
| 230001828 | 230006958 | 1.58 | 81.95 | Neo-adjuvant (N) | null | 2021-04-25 | null | null | N | CISPLATIN + FLUOROURACIL | 100446663 |
| 230001829 | 230006959 | 1.7 | 66.8 | Adjuvant (A) | 2020-11-10 | 2020-12-01 | null | null | N | FLUOROURACIL + IRINOTECAN | 100408458 |
| 230001976 | 230006960 | 1.57 | 65.9 | null | 2021-04-23 | 2021-06-06 | NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101770881 |
| 230002045 | 230006961 | 1.45 | 61 | null | null | 2017-12-25 | null | 01 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101121861 |
| 230002055 | 230006962 | 1.64 | 59.35 | null | 2017-12-06 | 2017-12-26 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101799681 |
| 230002111 | 230006964 | null | null | null | null | 2022-04-13 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101356988 |
| 230002135 | 230006965 | 1.63 | 50.2 | null | 2020-12-02 | 2020-12-05 | null | 02 | null | TRIAL UNSPECIFIED | 101119295 |
| 230002153 | 230006967 | 1.61 | null | null | 2019-10-10 | 2019-10-10 | null | Y | null | PEMBROLIZUMAB | 100775832 |
| 230002163 | 230006968 | 1.65 | 75.4 | null | null | 2022-02-12 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101233285 |
| 230002202 | 230006969 | 1.78 | 68 | Adjuvant (A) | null | 2016-12-22 | null | N | N | TRASTUZUMAB EMTANSINE | 101517166 |
| 230002313 | 230006971 | 1.5 | 50.4 | null | 2019-12-13 | 2020-01-03 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101541704 |
| 230002376 | 230006973 | 1.58 | 54.6 | Adjuvant (A) | 2021-01-24 | 2021-02-02 | Bevacizumab 15mg/kg | 99 | N | CARBOPLATIN | 100845043 |
| 230002409 | 230006975 | null | null | Neo-adjuvant (N) | 2018-07-28 | 2018-08-20 | Bevacizumab | 02 | N | BEVACIZUMAB | 100843848 |
| 230000346 | 230006976 | null | null | null | null | 2020-11-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101512272 |
| 230001178 | 230006978 | null | null | null | null | 2020-06-15 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101274660 |
| 230001248 | 230006979 | 1.62 | 58.3 | null | 2020-11-13 | 2020-12-09 | null | 02 | null | CISPLATIN | 100246213 |
| 230001673 | 230006983 | null | null | Palliative (P) | 2018-04-05 | 2018-04-16 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101631811 |
| 230001259 | 230007829 | null | null | null | null | 2016-04-18 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 100083370 |